Hyperion DeFi, Inc. (HYPD)
4.18
+0.14
(+3.59%)
USD |
NASDAQ |
May 01, 16:00
4.18
0.00 (0.00%)
After-Hours: 16:18
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 47.62M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 260.3% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 55.67 |
| Price to Book Value | 1.160 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.2074 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.84% |
Profile
| Hyperion DeFi, Inc. is a long-term strategic treasury of Hyperliquid’s native token HYPE. It provides investors with streamlined access to the Hyperliquid ecosystem and is also developing its proprietary Optejet user-filled device, designed for use with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The firm operates through the Ophthalmic Technology and Digital Assets segments. The Ophthalmic Technology segment focuses on developing eye-care devices and delivery systems for ophthalmic liquids. The Digital Assets segment focuses on managing a strategic treasury of blockchain-based assets and exposure to the Hyperliquid ecosystem. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA. |
| URL | http://hyperiondefi.com |
| Investor Relations URL | https://ir.eyenovia.com/ |
| HQ State/Province | California |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | May. 15, 2026 (est.) |
| Last Earnings Release | Nov. 13, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Hyperion DeFi, Inc. is a long-term strategic treasury of Hyperliquid’s native token HYPE. It provides investors with streamlined access to the Hyperliquid ecosystem and is also developing its proprietary Optejet user-filled device, designed for use with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The firm operates through the Ophthalmic Technology and Digital Assets segments. The Ophthalmic Technology segment focuses on developing eye-care devices and delivery systems for ophthalmic liquids. The Digital Assets segment focuses on managing a strategic treasury of blockchain-based assets and exposure to the Hyperliquid ecosystem. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in Laguna Hills, CA. |
| URL | http://hyperiondefi.com |
| Investor Relations URL | https://ir.eyenovia.com/ |
| HQ State/Province | California |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | May. 15, 2026 (est.) |
| Last Earnings Release | Nov. 13, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |